Literature DB >> 16978292

Prostate cells exposed to lycopene in vitro liberate lycopene-enriched exosomes.

Anuj Goyal1, George H Delves, Mridula Chopra, Bashir A Lwaleed, Alan J Cooper.   

Abstract

OBJECTIVES: To investigate whether cellular exosomes liberated by prostatic cell lines in culture might be acting as the transport vehicles for the dietary antioxidant lycopene, known to be sequestered in the prostate gland and to reduce the risk of developing benign prostatic hyperplasia (BPH) and prostate cancer; its subsequent secretion into seminal plasma also confers protection to spermatozoa against oxidative free-radical damage.
MATERIALS AND METHODS: Using benign and malignant human prostatic cell culture models, we assessed the role that their exosomes (the putative in vitro analogues of prostasomes) might have in the transport of lycopene.
RESULTS: Cells exposed to lycopene in vitro accumulated the molecule and secrete lycopene-enriched exosomes. This continued after the lycopene exposure was stopped. Extraction of lycopene from the exosomes, followed by high-performance liquid chromatography, confirmed nanogram quantities of lycopene per milligram of exosomal protein. Packaging into exosomes for export resulted in reduced degradation of this labile antioxidant, and therefore maximized the effectiveness of delivery to the sites of action.
CONCLUSION: These results support the likelihood that these organelles act as the transport vehicles for this important lipophilic agent known to have a role in the chemoprevention of various urological pathologies such as BPH, prostate cancer and male infertility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978292     DOI: 10.1111/j.1464-410X.2006.06434.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

Review 1.  Vitamin D receptor and RXR in the post-genomic era.

Authors:  Mark D Long; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

2.  Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.

Authors:  Nagi B Kumar; Karen Besterman-Dahan; Loveleen Kang; Julio Pow-Sang; Ping Xu; Kathy Allen; Diane Riccardi; Jeffrey P Krischer
Journal:  Clin Med Urol       Date:  2008-04-16

Review 3.  miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.

Authors:  Clayton Yates; Mark D Long; Moray J Campbell; Lara Sucheston-Campbell
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

Review 4.  Vitamin D and the RNA transcriptome: more than mRNA regulation.

Authors:  Moray J Campbell
Journal:  Front Physiol       Date:  2014-05-14       Impact factor: 4.566

5.  Antioxidant efficiency of lycopene on oxidative stress - induced damage in bovine spermatozoa.

Authors:  Eva Tvrdá; Anton Kováčik; Eva Tušimová; Dušan Paál; Alica Mackovich; Jakhongir Alimov; Norbert Lukáč
Journal:  J Anim Sci Biotechnol       Date:  2016-09-06

6.  Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.

Authors:  Nagi Kumar; Ganna Chornokur
Journal:  Transl Med (Sunnyvale)       Date:  2012-12-31

7.  Rhodobacter sphaeroides Extract Lycogen™ Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats.

Authors:  Chiang-Ting Wang; Ya-Yun Wang; Wen-Sheng Liu; Chun-Ming Cheng; Kuo-Hsun Chiu; Li-Lian Liu; Xue-Zhu Liu; Zhi-Hong Wen; Ya-Huey Chen; Tsung-Ming Chen
Journal:  Int J Mol Sci       Date:  2018-04-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.